Clinical Trial Drug Safety Assessment for Studies and Submissions Impacted by COVID-19

Mary Nilsson, Brenda Crowe, Greg Anglin +4

In this paper, we provide guidance on how standard safety analyses and reporting of clinical trial safety data may need to be modified, given the potential impact of the COVID-19 p…